Neurogene Inc.
NGNE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21 | -$22 | -$23 | -$20 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $4 | $2 |
| Change in WC | -$1 | -$0 | -$1 | -$1 |
| Other Non-Cash | $2 | -$1 | -$2 | -$0 |
| Operating Cash Flow | -$20 | -$19 | -$21 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$78 | -$60 | -$89 | -$118 |
| Inv. Sales/Matur. | $101 | $68 | $45 | $16 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $22 | $7 | -$45 | -$103 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $10 | $0 | $0 | $186 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $4 |
| Financing Cash Flow | $10 | $0 | $0 | $190 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12 | -$12 | -$66 | $70 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59 | $71 | $137 | $67 |
| End Cash | $71 | $59 | $71 | $137 |
| Free Cash Flow | -$20 | -$20 | -$22 | -$18 |